Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BeiGene Ltd (NASDAQ:BGNE)

115.56
Delayed Data
As of 4:00pm ET
 +12.93 / +12.60%
Today’s Change
31.74
Today|||52-Week Range
119.60
+18.26%
Year-to-Date
No recent news for BeiGene Ltd.

Today’s Trading

Previous close102.63
Today’s open109.46
Day’s range109.46 - 119.60
Volume1,544,993
Average volume (3 months)303,128
Market cap$4.7B
Data as of 4:00pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+42.39%
Earnings growth (this year)+63.11%
Earnings growth (next 5 years)--
Revenue growth (last year)-87.88%
P/E ratioNM
Price/Sales882.71
Price/Book11.54

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...-0.85-12.14%
OASMOasmia Pharmaceutica...-0.08-7.02%
TEVATeva Pharmaceutical-0.77-3.58%
Data as of 4:00pm ET, 01/18/2018

Financials

Next reporting dateMarch 22, 2018
EPS forecast (this quarter)-$1.42
Annual revenue (last year)$1.1M
Annual profit (last year)-$119.0M
Net profit margin-11,141.78%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John V. Oyler
Head-
Operations
Maggie Liu
Corporate headquarters
Beijing, Beijing

Forecasts